2.1 WHY DO WE NEED NEW GUIDELINES ON VALVULAR HEART DISEASE? Since the publication of the previous version of the guidelines on the management of valvular heart disease (VHD) in 2017, new evidence has accumulated, particularly on the following topics: Epidemiology: the incidence of ...
valvular heart disease? 2023 American College of Cardiology FoundationValvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these ...
No substantial updates were noted with respect to prosthetic valves or heart disease and pregnancy. The most important take away: the integral role of the heart team in the management of valvular heart disease! Given the rapid developments in this field, the guidelines will ...
RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation RIVER研究:利伐沙班在瓣膜性心脏病合并心房颤动患者中的应用 EXPLORER-CN - Efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy EXPLORER-CN研究:Mavacamten治疗中国成人症状性梗阻性肥...
1. Alec Vahanian, Friedhelm Beyersdorf, Fabien Praz. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal (2021) 00, 1-72. doi:10.1093/eurheartj/ehab395. 2. Otto CM, Nish...
[2] Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical PracticeGuidelines. Circulation, 2021, 145 (5...
2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) ...
RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation RIVER研究:利伐沙班在瓣膜性心脏病合并心房颤动患者中的应用 EXPLORER-CN - Efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive ...
3.Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of PatientsWith Valvular Heart Disease: A Report of the American College of Cardiology/American HeartAssociation Task Force on Clinical Practice Guidelines. J Am Coll Cardi...
Keywords Valvular heart disease 1. Preamble The joint ESC and EACTS guidelines help physicians in selecting the best management strategies for an individual patient with valvular heart disease. The level of evidence and the strength of recommendation are outlined in Tables 1 and 2. The Czech Society...